Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Escalating drug prices are at the centre of the raging debates on the seemingly uncon-trollable costs of providing healthcare. Making available generic substitutes for the more expensive, patented drugs is a core element of many healthcare cost-reduction plans. In the United States, the Orange Book serves to promote expedited entry of generic drugs into the marketplace while simultaneously protecting the interest of drug patent owners.
